Back to today’s briefing

Story perspectives

Breakthrough Sugar Molecules Slash Type 1 Diabetes Risk

8/22/2025

25 2

Summary

Story summary

Mayo Clinic researchers are advancing type 1 diabetes prevention by using sugar molecules to protect pancreatic tissue.
In tests with genetically engineered mice, only 6% developed diabetes, versus 60% in untreated mice.
Engineered beta cells appear to evade immune attacks while preserving immune function.
These findings, published in the Journal of Clinical Investigation, could enhance diabetes treatment.

1 of 1

Story summary

Mayo Clinic researchers are advancing type 1 diabetes prevention by using sugar molecules to protect pancreatic tissue.
In tests with genetically engineered mice, only 6% developed diabetes, versus 60% in untreated mice.
Engineered beta cells appear to evade immune attacks while preserving immune function.
These findings, published in the Journal of Clinical Investigation, could enhance diabetes treatment.